Champions Oncology (CSBR) announced advancements in its bioanalytical services portfolio, specifically, expanding its capabilities with the ...

Cytek Biosciences (CTKB) announced that its Board of Directors has approved a stock repurchase program for up to an additional aggregate of $50 ...

Despite that underperformance, I believe that the tide might be already turning in Cytek's favor: being a leading cellular analysis instrument maker with still a nicely expanding market TAM ...

FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the ...

https://www.tipranks.com/news/the-fly/champions-oncology-integrates-cytek-aurora-flow-cytometers Champions Oncology (CSBR) announced advancements in its bioanalytical ...

Cytek Biosciences, Inc. has announced a new stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $50 million of its common stock starting January 1 ...

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) shares traded up 5.9% during mid-day trading on Monday .The company traded as high as $6.83 and last traded at $6.77. 97,485 shares ...

FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming ...

U.S. stocks were lower, with the Dow Jones index falling more than 700 points on Monday. Shares of Cytek Biosciences, Inc. CTKB rose sharply during Monday's session. Cytek Biosciences announced a ...